[{"address1": "2001 Market Street", "address2": "Suite 3915 Unit #15", "city": "Philadelphia", "state": "PA", "zip": "19103", "country": "United States", "phone": "(267) 225-7416", "website": "https://www.contexttherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Context Therapeutics Inc., a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. Context Therapeutics Inc. was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.", "fullTimeEmployees": 5, "companyOfficers": [{"maxAge": 1, "name": "Mr. Martin A. Lehr", "age": 39, "title": "Co-Founder, President, CEO & Director", "yearBorn": 1984, "fiscalYear": 2023, "totalPay": 674083, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jennifer  Minai-Azary", "age": 45, "title": "CFO & Treasurer", "yearBorn": 1978, "fiscalYear": 2023, "totalPay": 504143, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alex C. Levit Esq.", "age": 44, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1979, "fiscalYear": 2023, "totalPay": 483831, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher  Beck M.B.A.", "title": "Senior Vice President of Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Claudio  Dansky Ullmann M.D.", "title": "Chief Medical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.9784, "open": 0.98, "dayLow": 0.93, "dayHigh": 1.05, "regularMarketPreviousClose": 0.9784, "regularMarketOpen": 0.98, "regularMarketDayLow": 0.93, "regularMarketDayHigh": 1.05, "beta": 2.246, "forwardPE": -3.3388429, "volume": 259944, "regularMarketVolume": 259944, "averageVolume": 563840, "averageVolume10days": 376790, "averageDailyVolume10Day": 376790, "bid": 0.9702, "ask": 1.05, "bidSize": 100, "askSize": 100, "marketCap": 75748288, "fiftyTwoWeekLow": 0.89, "fiftyTwoWeekHigh": 2.75, "fiftyDayAverage": 1.45396, "twoHundredDayAverage": 1.854585, "currency": "USD", "enterpriseValue": 64959420, "floatShares": 39074121, "sharesOutstanding": 74998304, "sharesShort": 1025078, "sharesShortPriorMonth": 1692626, "sharesShortPreviousMonthDate": 1726185600, "dateShortInterest": 1728950400, "sharesPercentSharesOut": 0.0137, "heldPercentInsiders": 0.01447, "heldPercentInstitutions": 0.76401, "shortRatio": 2.79, "shortPercentOfFloat": 0.0154, "impliedSharesOutstanding": 74998304, "bookValue": 0.744, "priceToBook": 1.3575268, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -18566876, "trailingEps": -0.88, "forwardEps": -0.29, "enterpriseToEbitda": -3.246, "52WeekChange": -0.06411481, "SandP52WeekChange": 0.22408533, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "CNTX", "underlyingSymbol": "CNTX", "shortName": "Context Therapeutics Inc.", "longName": "Context Therapeutics Inc.", "firstTradeDateEpochUtc": 1634736600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "9370db4d-3fc8-33de-8dd0-aba14eeca611", "messageBoardId": "finmb_408000800", "gmtOffSetMilliseconds": -18000000, "currentPrice": 1.01, "targetHighPrice": 10.0, "targetLowPrice": 4.0, "targetMeanPrice": 7.08333, "targetMedianPrice": 7.0, "recommendationMean": 1.66667, "recommendationKey": "buy", "numberOfAnalystOpinions": 6, "totalCash": 101536832, "totalCashPerShare": 1.354, "ebitda": -20014956, "quickRatio": 63.289, "currentRatio": 64.013, "returnOnAssets": -0.19186, "returnOnEquity": -0.29681, "freeCashflow": -12332572, "operatingCashflow": -18404430, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2025-01-18"}]